Division of Cardiology (V.N.R., J.M., S.G.B., M.D.K., S.J.G., M.F., A.D.D., C.B.P., M.A.B., R.J.M.), Duke University Medical Center, Durham, NC.
Duke Clinical Research Institute, Durham, NC (V.N.R., M.D.K., S.J.G., M.F., A.D.D., R.J.M.).
Circ Heart Fail. 2023 Feb;16(2):e010158. doi: 10.1161/CIRCHEARTFAILURE.122.010158. Epub 2022 Oct 31.
Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) improves clinical outcomes and quality of life. Optimizing GDMT in the hospital is associated with greater long-term use in HFrEF. This study aimed to describe the efficacy of a multidisciplinary virtual HF intervention on GDMT optimization among patients with HFrEF admitted for any cause.
In this pilot randomized, controlled study, consecutive patients with HFrEF admitted to noncardiology medicine services for any cause were identified at a large academic tertiary care hospital between May to September 2021. Major exclusions were end-stage renal disease, hemodynamic instability, concurrent COVID-19 infection, and current enrollment in hospice care. Patients were randomized to a clinician-level virtual peer-to-peer consult intervention providing GDMT recommendations and information on medication costs versus usual care. Primary end points included (1) proportion of patients with new GDMT initiation or use and (2) changes to HF optimal medical therapy scores which included target dosing (range, 0-9).
Of 242 patients identified, 91 (38%) were eligible and randomized to intervention (N=52) or usual care (N=39). Baseline characteristics were similar between intervention and usual care (mean age 63 versus 67 years, 23% versus 26% female, 46% versus 49% Black, mean ejection fraction 33% versus 31%). GDMT use on admission was also similar. There were greater proportions of patients with GDMT initiation or continuation with the intervention compared with usual care. After adjusting for optimal medical therapy score on admission, changes to optimal medical therapy score at discharge were higher for the intervention group compared with usual care (+0.44 versus -0.31, absolute difference +0.75, adjusted estimate 0.86±0.42; =0.041).
Among eligible patients with HFrEF hospitalized for any cause on noncardiology services, a multidisciplinary pilot virtual HF consultation increased new GDMT initiation and dose optimization at discharge.
针对射血分数降低的心力衰竭(HFrEF)的指南指导的医学治疗(GDMT)可改善临床结局和生活质量。优化医院内的 GDMT 与 HFrEF 患者长期使用 GDMT 的比例增加有关。本研究旨在描述多学科虚拟心力衰竭干预措施对因任何原因入住非心内科病房的 HFrEF 患者 GDMT 优化的效果。
这是一项在 2021 年 5 月至 9 月期间于一家大型学术型三级保健医院进行的、连续纳入因任何原因入住非心内科病房的 HFrEF 患者的试点随机对照研究。主要排除标准为终末期肾病、血流动力学不稳定、同时感染 COVID-19 以及正在接受临终关怀。患者被随机分配至临床医生级别的虚拟同行咨询干预组,该组提供 GDMT 建议和药物费用信息,与常规护理组进行比较。主要终点包括(1)新开始或继续使用 GDMT 的患者比例,以及(2)心力衰竭最佳药物治疗评分的变化,该评分包括目标剂量(范围 0-9)。
共确定了 242 例患者,其中 91 例(38%)符合条件并被随机分配至干预组(n=52)或常规护理组(n=39)。干预组和常规护理组的基线特征相似(平均年龄 63 岁 vs 67 岁,23% vs 26%为女性,46% vs 49%为黑人,平均射血分数 33% vs 31%)。入院时的 GDMT 使用情况也相似。与常规护理组相比,接受干预的患者有更多的患者开始或继续使用 GDMT。调整入院时最佳药物治疗评分后,与常规护理组相比,干预组出院时最佳药物治疗评分的变化更高(+0.44 对-0.31,绝对差值为+0.75,调整估计值为 0.86±0.42;P=0.041)。
在因任何原因入住非心内科病房的 HFrEF 患者中,多学科虚拟心力衰竭咨询增加了新的 GDMT 起始和出院时剂量优化。